H.R. 7352: PASTEUR Act of 2026

H.R. 7352 is a federal bill in the 119th Congress. Today, pharmaceutical companies have little financial incentive to develop new antibiotics because these drugs are used sparingly to prevent drug resistance, leading to low sales revenue. Under this bill, the federal government will enter into contracts… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.